Multicentre study of the reduction of steps (measured by an electronic pedometer) after 4 different types of repair for inguinal hernia
| ISRCTN | ISRCTN34433965 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN34433965 |
| Protocol serial number | B.U.N. B14320072331 |
| Sponsor | Royal Belgian Society of Surgery, Section of Abdominal Wall Surgery (BSAWS) (Belgium) |
| Funder | Royal Belgian Society of Surgery, Section of Abdominal Wall Surgery (BSAWS) (Belgium) |
- Submission date
- 29/05/2008
- Registration date
- 20/06/2008
- Last edited
- 20/06/2008
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Digestive System
Plain English summary of protocol
Not provided at time of registration
Contact information
Scientific
Laarbeeklaan 101
Brussels
1090
Belgium
Study information
| Primary study design | Observational |
|---|---|
| Study design | Prospective, multicentre, cohort, observational study |
| Secondary study design | Cohort study |
| Study type | Participant information sheet |
| Scientific title | Multicentre cohort study evaluating ambulatory activity reduction after LIchtenstein, laparoscopic Totally ExtraPeritoneal, KUgel patch or Polysoft repair of primary inguinal hernia (LITEKUP trial) |
| Study acronym | LITEKUP trial |
| Study objectives | To compare the short-term functional outcome after four different techniques of inguinal hernia repair in an ambulatory setting, namely, the Lichtenstein repair, the laparoscopic totally extraperitoneal repair, the open retroperitoneal Kugel patch repair and the Polysoft® patch repair. |
| Ethics approval(s) | Leading Ethical Committee of the University Hospital Brussels (Universitair Ziekenhuis Brussel). Date of approval: 11/10/2007 |
| Health condition(s) or problem(s) studied | Inguinal hernia |
| Intervention | This is an observational cohort study comparing the reduction in ambulatory activity (RAA) after four common techniques of inguinal hernia repair of patients with primary inguinal hernia. The four techniques are: 1. Lichtenstein repair 2. Laparoscopic totally extraperitoneal repair 3. Open retroperitoneal Kugel patch repair 4. Polysoft® patch repair Count of steps will be carried out 1 week before and 2 weeks after scheduled inguinal hernia repair, measured with an electronic pedometer. |
| Intervention type | Other |
| Primary outcome measure(s) |
Count of steps 1 week before and 2 weeks after scheduled inguinal hernia repair, measured with an electronic pedometer. |
| Key secondary outcome measure(s) |
1. Recurrence rate after 12-24 months. This will be assessed by clinical examination during clinical follow-up after 2 weeks, 6, 12 and 24 months. Independent examination will be performed at 12 and 24 months to assess recurrence and chronic pain. |
| Completion date | 31/05/2012 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Adult |
| Lower age limit | 18 Years |
| Sex | All |
| Target sample size at registration | 976 |
| Key inclusion criteria | Consecutive patients (both males and females, >18 years of age) with a diagnosis of primary unilateral inguinal hernia presenting in the participating centres for the surgical repair of their hernia in an ambulatory setting. |
| Key exclusion criteria | 1. Incarcerated inguinal hernia 2. Life expectancy less than two years 3. Pregnancy 4. American Society of Anaesthesiology (ASA) class IV or V 5. Extensive lower abdominal surgery or severe local inflammation 6. Inability to sign the informed consent. 7. Indication for other type of surgery for various reasons 8. Patients unable to walk (paralysed or bedridden patients) 9. Bilateral hernia repair 10. Large scrotal hernias 11. Concomitant abdominal surgery 12. Body mass index (BMI) >= 35 kg/m2 13. Liver cirrhosis (Child C) 14. Known abuse of alcohol or drugs 15. Ongoing long term analgesic or steroid treatment 16. Patients under clopidogrel or warfarin must be switched to subcutaneous (sc) low-molecular-weight (lmw) heparin 17. Severely compromised physical or psychological health, that in the investigators opinion will affect patients compliance 18. Concurrently participating in another clinical trial |
| Date of first enrolment | 01/06/2008 |
| Date of final enrolment | 31/05/2012 |
Locations
Countries of recruitment
- Belgium
Study participating centre
1090
Belgium
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | Not provided at time of registration |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Participant information sheet | Participant information sheet | 11/11/2025 | 11/11/2025 | No | Yes |